SupplySide Constraints and Weather Patterns Cloud Indias Macroeconomic Outlook USIran Peace Talks Show Progress but Key Disputes Over Uranium and Strait of Hormuz Tolls Remain Prediction Markets Signal Potential Fed Rate Hike by July 2027 Jim Cramer Cites Equinix as a Data Center Play Amid Growing Digital Infrastructure Demand Mortgage Rate Shopping How Comparing Lenders Could Save Thousands Were Not in a Bubble Wall Street Just Hasnt Caught Up With the New Physics of the Stock Market PRG Q1 2026 Earnings Massive EPS Beat Surprises But Market Response Remains Subdued Dave Inc Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise Despite Stock Pullback Backblaze BLZE Q1 2026 Earnings EPS Misses Estimates but Stock Gains 4 on Operational Momentum BCAL Q1 2026 Earnings EPS Surprise of 276 Highlights Solid Performance Despite Minor Stock Decline HSY Q1 2026 Earnings Earnings Beat Drives Solid Share Rally PHAT Q1 2026 Earnings Missed EPS Estimates Amid Ongoing Development Efforts UWM Holdings Stock Edges Higher Key Levels and Market Dynamics at 309 Evolution Global Acquisition Corp Units EVOXU Holds Steady at 1017 Amid Consolidation Sangoma Technologies SANG Edges Higher Testing Key Resistance After 278 Gain Tenon Medical Inc Warrant TNONW Holds at 001 as Trading Volume Remains Minimal Methode Electronics MEI Surges 383 as Shares Test Key Resistance Near 1225 Nvidia Faces PostEarnings Dip Why Some Investors May Be Overlooking LongTerm Potential MasterBrand Inc MBC Q1 2026 Earnings EPS Surges Past Estimates Stock Reacts Positively BJs Restaurants Inc BJRI Edges Higher as Shares Test Key Technical Levels Nexentis Technologies NXTS Surges 154 Momentum Builds Above Key Support Clough Global Dividend and Income Fund GLV Edges Higher as Price Holds Above Support Glimpse Group Inc GGRP Tests Support at 077 After 357 Decline SB Financial Group SBFG Shares Rise 149 as Stock Approaches Key Resistance Level Carlisle Companies CSL Holds Steady Near Resistance Whats Driving the Move FTAIN Preferred Shares Hold Steady Near Par as Investors Weigh Rate Environment Silexion Therapeutics SLXN Slips 3 as Shares Test Key Support at 040